Craig Magaret

17PUBLICATIONS
148CO-AUTHORS
Predictive and prognostic markersInnate immunityNanotoxicology, health and safetyMedical biotechnology diagnostics (incl. biosensors)Molecular evolution
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 04, 2026
Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants.

|Nov 04, 2026
Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections.

|Oct 28, 2026
mRNA-1273 SARS-CoV-2 vaccination in people with HIV: an immune correlates analysis of CD4 + T cell responses in the multicenter CoVPN 3008 observational study.

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 24, 2026
Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial.

|Sep 08, 2026
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

Pageof 3

Frequent Collaborators

14 joint publications

Peter Gilbert

13 joint publications

Lawrence Corey

10 joint publications

Lindsay N Carpp

10 joint publications

Michal Juraska